24/7 SUPPORT

+91 9342525252

Shopping cart
  • Your shopping cart is empty!

Shopping cart
  • Your shopping cart is empty!

Shopping Cart
  • Your shopping cart is empty!

Login
0 WishList
0 Compare
0 View Cart

Glitaris M 15 Tablet SR

0 reviews / Write a review

₹97.00

  • Product Code: MED524
  • Availability: In Stock

Manufacturers

Eris Lifesciences Ltd

Salt Composition

Pioglitazone (15mg) + Metformin (500mg)

Medicine Type

drugs

Introduction

In Treatment of Type 2 diabetes mellitus Glitaris M 15 Tablet SR is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. It also improves the body’s response to the hormone insulin, which is responsible for regulating blood glucose (sugar) levels in our body. The insulin helps to lower your blood glucose levels and prevents them from rising after taking meals. You should keep taking it for as long as it is prescribed.u003cbr>Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.

Benefits

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glitaris M 15 Tablet SR is to be taken with food.

Description

Glitaris M 15 Tablet SR is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar level.Glitaris M 15 Tablet SR should be taken in the dose and duration as advised by your doctor. It must be taken with food to avoid stomach upset. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose. Overdose may lead to low blood sugar (hypoglycemia).Some people may develop common side effects like nausea, loss of appetite, taste changes, stomach pain, diarrhea, and edema (swelling). However, these are usually not bothersome. If these do not resolve or worry you, please consult your doctor.Before taking this medicine, inform your doctor if you have any kidney, liver or heart problems. Pregnant or breastfeeding women should also consult their doctor before taking it. Your doctor will check your kidney function tests before starting treatment with it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects.

How To Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glitaris M 15 Tablet SR is to be taken with food.

Safety Advise

- Alcohol : UNSAFE

It is unsafe to consume alcohol with Glitaris M 15 Tablet SR. | - Pregnancy : CONSULT YOUR DOCTOR

Glitaris M 15 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR

Glitaris M 15 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. | - Driving : CAUTION

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur. | - Kidney : CAUTION

Glitaris M 15 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glitaris M 15 Tablet SR may be needed. Please consult your doctor.Use of Glitaris M 15 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine. | - Liver : CAUTION

Glitaris M 15 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glitaris M 15 Tablet SR may be needed. Please consult your doctor.Glitaris M 15 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

If Miss

If you miss a dose of Glitaris M 15 Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Packaging Detail

strip of 10 tablet sr

Package

Strip

Qty

10

Product Form

Tablet SR

Prescription Required

Prescription Required

Fact Box

Habit Forming :: No|Therapeutic Class :: ANTI DIABETIC

Primary Use

Treatment of Type 2 diabetes mellitus

Storage

Store below 30°C

Use Of

Treatment of Type 2 diabetes mellitus

Common Side Effect

Diarrhea | Edema (swelling) | Headache | Nausea | Vomiting | Hypoglycemia (low blood glucose level) | Dizziness | Urinary tract infection | Upper respiratory tract infection | Sinus infection

Alcoholinteraction

UNSAFE

Pregnancyinteraction

CONSULT YOUR DOCTOR

Lactationinteraction

CONSULT YOUR DOCTOR

Drivinginteraction

CAUTION

Kidneyinteraction

CAUTION

Liverinteraction

CAUTION

Manufacturer Address

8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

How It Works

Glitaris M 15 Tablet SR is a combination of two antidiabetic medicines:.

Marketer Details

Eris Lifesciences Ltd | 8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Reference

Pioglitazone hydrochloride and metformin hydrochloride. Deerfield, Illinois: Takeda Pharmaceuticals America, Inc; 2011. [Accessed 08 Apr. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021842s014s015lbl.pdf | Pioglitazone and metformin hydrochloride (Competact) [Summary of Product Characteristics]. Wicklow, Ireland: Takeda Ireland Limited; 2021. [Accessed 26 Oct. 2021] (online) Available from: https://www.ema.europa.eu/en/documents/product-information/competact-epar-product-information_en.pdf | Pioglitazone and metformin hydrochloride [Prescribing Information]. Deerfield, IL: Takeda Pharmaceuticals America, Inc.; 2016. [Accessed 28th Sept. 2023] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021842s20-21lbl.pdf | Pioglitazone and metformin hydrochloride [Medication Guide]. Morgantown, WV: Mylan Pharmaceuticals Inc.; 2015. [Accessed 28th Sept. 2023] (online) Available from: https://online.lexi.com/lco/medguides/613902.pdf

Write a review

Note: HTML is not translated!
    Bad           Good